Repligen | RGEN - Stock



Repligen reported $153.11M in Stock for its fiscal quarter ending in March of 2025.


Stock Change Date
Agilent USD 1.01B 23M Jul/2025
Align Technology USD 246.57M 7.72M Mar/2025
Bio Techne USD 189.45M 1.64M Jun/2025
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Bruker USD 1.22B 101.8M Jun/2025
Charles River Laboratories USD 279.55M 10.61M Jun/2025
Danaher USD 2.69B 157M Jun/2025
Dentsply International USD 675M 63M Jun/2025
Exact Sciences USD 171.5M 5.08M Jun/2025
General Electric Aerospace USD 11.3B 793M Jun/2025
Henry Schein USD 1.91B 66M Jun/2025
Illumina USD 575M 38M Jun/2025
Mettler Toledo International USD 388.08M 29.3M Jun/2025
Myriad Genetics USD 28.3M 800K Mar/2025
Pfizer USD 11.67B 817M Jun/2025
Repligen USD 153.11M 10.15M Mar/2025
Revvity USD 388.47M 7.16M Jun/2025
Standard Biotools USD 24.17M 16.57M Jun/2025
Thermo Fisher Scientific USD 5.56B 335M Jun/2025
Waters USD 540.75M 29.26M Jun/2025
West Pharmaceutical Services USD 421.1M 32.4M Jun/2025